$10.47
2.15%
NYSE, Sep 18, 04:00 pm EDT. Closed.
ISIN
US03980N1072
Symbol
ARDT

Ardent Health Inc Target price 2026 - Analyst rating & recommendation

Ardent Health Inc Classifications & Recommendation

Buy
67%
Hold
28%
Sell
6%

Ardent Health Inc Price Target

Target Price $13.26
Price $10.48
Potential
Number of Estimates 13
13 Analysts have issued a price target Ardent Health Inc 2027 . The average Ardent Health Inc target price is $13.26. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 18 analysts: 12 Analysts recommend Ardent Health Inc to buy, 5 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Ardent Health Inc stock has an average upside potential 2027 of . Most analysts recommend the Ardent Health Inc stock at Purchase.

Sales and Margin forecast 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Billion $ 6.32 6.59
6.01% 4.20%
EBITDA Margin 7.61% 7.78%
17.76% 2.23%
Net Margin 2.15% 2.05%
39.09% 4.54%

13 Analysts have issued a sales forecast Ardent Health Inc 2026 . The average Ardent Health Inc sales estimate is

$6.6b
unlock
. This is
2.87% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$6.8b 6.71%
unlock
, the lowest is
$6.3b 2.09%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $6.3b 6.01%
2026
$6.6b 4.20%
unlock
2027
$6.9b 4.23%
unlock
2028
$7.2b 4.29%
unlock

14 Analysts have issued an Ardent Health Inc EBITDA forecast 2026. The average Ardent Health Inc EBITDA estimate is

$513m
unlock
. This is
23.56% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$557m 34.23%
unlock
, the lowest is
$475m 14.51%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $481m 12.82%
2026
$513m 6.56%
unlock
2027
$537m 4.66%
unlock
2028
$563m 4.90%
unlock

EBITDA Margin

2025 7.61% 17.76%
2026
7.78% 2.23%
unlock
2027
7.81% 0.39%
unlock
2028
7.86% 0.64%
unlock

13 Ardent Health Inc Analysts have issued a net profit forecast 2026. The average Ardent Health Inc net profit estimate is

$135m
unlock
. This is
72.54% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$156m 100.00%
unlock
, the lowest is
$108m 38.67%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $136m 35.43%
2026
$135m 0.61%
unlock
2027
$165m 22.53%
unlock
2028
$178m 7.35%
unlock

Net Margin

2025 2.15% 39.09%
2026
2.05% 4.54%
unlock
2027
2.41% 17.56%
unlock
2028
2.48% 2.90%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ 0.96 0.95
39.24% 1.04%
P/E 11.02
EV/Sales 0.28

13 Analysts have issued a Ardent Health Inc forecast for earnings per share. The average Ardent Health Inc EPS is

$0.95
unlock
. This is
72.73% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$1.10 100.00%
unlock
, the lowest is
$0.76 38.18%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $0.96 39.24%
2026
$0.95 1.04%
unlock
2027
$1.17 23.16%
unlock
2028
$1.25 6.84%
unlock

P/E ratio

Current 19.05 163.68%
2026
11.02 42.17%
unlock
2027
8.99 18.42%
unlock
2028
8.38 6.79%
unlock

Based on analysts' sales estimates for 2026, the Ardent Health Inc stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.29 25.64%
2026
0.28 2.90%
unlock
2027
0.27 4.08%
unlock
2028
0.26 4.11%
unlock

P/S ratio

Current 0.23 23.61%
2026
0.22 2.77%
unlock
2027
0.22 4.06%
unlock
2028
0.21 4.14%
unlock

Current Ardent Health Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Leerink Partners
Locked
Locked
Locked Sep 18 2026
RBC Capital
Locked
Locked
Locked Aug 10 2026
Guggenheim
Locked
Locked
Locked Aug 06 2026
Truist Securities
Locked
Locked
Locked Aug 06 2026
Truist Securities
Locked
Locked
Locked Jul 14 2026
RBC Capital
Locked
Locked
Locked Jul 09 2026
UBS
Locked
Locked
Locked May 07 2026
Analyst Rating Date
Locked
Leerink Partners:
Locked
Locked
Sep 18 2026
Locked
RBC Capital:
Locked
Locked
Aug 10 2026
Locked
Guggenheim:
Locked
Locked
Aug 06 2026
Locked
Truist Securities:
Locked
Locked
Aug 06 2026
Locked
Truist Securities:
Locked
Locked
Jul 14 2026
Locked
RBC Capital:
Locked
Locked
Jul 09 2026
Locked
UBS:
Locked
Locked
May 07 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today